These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23860602)

  • 1. The effect of pre-adapting light intensity on dark adaptation in early age-related macular degeneration.
    Gaffney AJ; Binns AM; Margrain TH
    Doc Ophthalmol; 2013 Dec; 127(3):191-9. PubMed ID: 23860602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topography of cone dark adaptation deficits in age-related maculopathy.
    Gaffney AJ; Binns AM; Margrain TH
    Optom Vis Sci; 2011 Sep; 88(9):1080-7. PubMed ID: 21705940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Light and the Dark of Early and Intermediate AMD: Cone- and Rod-Mediated Changes Are Linked to Fundus Photograph and FAF Abnormalities.
    Rodrigo-Diaz E; Tahir HJ; Kelly JM; Parry NRA; Aslam T; Murray IJ
    Invest Ophthalmol Vis Sci; 2019 Dec; 60(15):5070-5079. PubMed ID: 31801157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring rod and cone dynamics in age-related maculopathy.
    Dimitrov PN; Guymer RH; Zele AJ; Anderson AJ; Vingrys AJ
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):55-65. PubMed ID: 18172075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local Abundance of Macular Xanthophyll Pigment Is Associated with Rod- and Cone-Mediated Vision in Aging and Age-Related Macular Degeneration.
    Kar D; Clark ME; Swain TA; McGwin G; Crosson JN; Owsley C; Sloan KR; Curcio CA
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):46. PubMed ID: 32729911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cone- and rod-mediated dark adaptation impairment in age-related maculopathy.
    Owsley C; McGwin G; Jackson GR; Kallies K; Clark M
    Ophthalmology; 2007 Sep; 114(9):1728-35. PubMed ID: 17822978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Cone- and Rod-Mediated Parameters in Dark Adaptation Testing as Outcome Measures in Age-Related Macular Degeneration.
    Hess K; de Silva T; Grisso P; Wiley H; Thavikulwat AT; Keenan TDL; Chew EY; Cukras CA
    Ophthalmol Retina; 2022 Dec; 6(12):1173-1184. PubMed ID: 35643387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging and cone dark adaptation.
    Gaffney AJ; Binns AM; Margrain TH
    Optom Vis Sci; 2012 Aug; 89(8):1219-24. PubMed ID: 22773176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual function tests as potential biomarkers in age-related macular degeneration.
    Dimitrov PN; Robman LD; Varsamidis M; Aung KZ; Makeyeva GA; Guymer RH; Vingrys AJ
    Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9457-69. PubMed ID: 22003115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Rod Function Phenotypes Across a Range of Age-Related Macular Degeneration Severities and Subretinal Drusenoid Deposits.
    Flynn OJ; Cukras CA; Jeffrey BG
    Invest Ophthalmol Vis Sci; 2018 May; 59(6):2411-2421. PubMed ID: 29847647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functionally validated imaging endpoints in the Alabama study on early age-related macular degeneration 2 (ALSTAR2): design and methods.
    Curcio CA; McGwin G; Sadda SR; Hu Z; Clark ME; Sloan KR; Swain T; Crosson JN; Owsley C
    BMC Ophthalmol; 2020 May; 20(1):196. PubMed ID: 32429847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed Rod-Mediated Dark Adaptation Is a Functional Biomarker for Incident Early Age-Related Macular Degeneration.
    Owsley C; McGwin G; Clark ME; Jackson GR; Callahan MA; Kline LB; Witherspoon CD; Curcio CA
    Ophthalmology; 2016 Feb; 123(2):344-351. PubMed ID: 26522707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slowed dark adaptation in older eyes; effect of location.
    Tahir HJ; Rodrigo-Diaz E; Parry NR; Kelly JM; Carden D; Murray IJ
    Exp Eye Res; 2017 Feb; 155():47-53. PubMed ID: 27890475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Evaluation of a Battery of Functional and Structural Tests as Predictors of Likely Risk of Progression of Age-Related Macular Degeneration.
    Robinson DG; Margrain TH; Bailey C; Binns AM
    Invest Ophthalmol Vis Sci; 2019 Feb; 60(2):580-589. PubMed ID: 30721275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration.
    Mullins RF; McGwin G; Searcey K; Clark ME; Kennedy EL; Curcio CA; Stone EM; Owsley C
    Ophthalmology; 2019 Apr; 126(4):591-600. PubMed ID: 30389424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining Optimal Test Parameters for Assessing Dark Adaptation in People With Intermediate Age-Related Macular Degeneration.
    Binns AM; Taylor DJ; Edwards LA; Crabb DP
    Invest Ophthalmol Vis Sci; 2018 Mar; 59(4):AMD114-AMD121. PubMed ID: 30105357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slowed Dark Adaptation in Early AMD: Dual Stimulus Reveals Scotopic and Photopic Abnormalities.
    Tahir HJ; Rodrigo-Diaz E; Parry NRA; Kelly JMF; Carden D; Aslam TM; Murray IJ
    Invest Ophthalmol Vis Sci; 2018 Mar; 59(4):AMD202-AMD210. PubMed ID: 30398565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relating Retinal Morphology and Function in Aging and Early to Intermediate Age-related Macular Degeneration Subjects.
    Sevilla MB; McGwin G; Lad EM; Clark M; Yuan EL; Farsiu S; Curcio CA; Owsley C; Toth CA
    Am J Ophthalmol; 2016 May; 165():65-77. PubMed ID: 26940163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repeatability of Rod-Mediated Dark Adaptation Testing in Normal Aging and Early and Intermediate Age-Related Macular Degeneration.
    Owsley C; Swain TA; McGwin G; Bernard MM; Clark ME; Curcio CA
    Curr Eye Res; 2024 Jul; 49(7):725-730. PubMed ID: 38439539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between abnormal rod-mediated dark adaptation and health and functioning in older adults with normal macular health.
    Owsley C; Huisingh C; Jackson GR; Curcio CA; Szalai AJ; Dashti N; Clark M; Rookard K; McCrory MA; Wright TT; Callahan MA; Kline LB; Witherspoon CD; McGwin G
    Invest Ophthalmol Vis Sci; 2014 May; 55(8):4776-89. PubMed ID: 24854857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.